Doxycycline sustained release from brushite cements for the treatment of periodontal diseases

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 3, 2008, Pages 707-714

  Tamimi, Faleh ^a   Torres, Jesús ^b   Bettini, Ruggero ^c   Ruggera, Francesca ^c   Rueda, Carmen ^a   López Ponce, Manuel ^a   Lopez Cabarcos, Enrique ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Brushite cement; Controlled release; Doxycycline; Periodontal pathogens; Solid state fluorescence

Indexed keywords

BIOMATERIALS; BONE; CALCIUM PHOSPHATE; DIFFUSION; DISEASES; DRUG DELIVERY; FLUORESCENCE;

BRUSHITE CEMENT; CONTROLLED RELEASE; INFECTIONS; PERIODONTAL PATHOGENS;

CEMENTS;

CALCIUM ION; CALCIUM PHOSPHATE DIBASIC; DOXYCYCLINE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; DIFFUSION; FLUORESCENCE; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; SOLID STATE; SUSTAINED DRUG RELEASE; TANNERELLA FORSYTHENSIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTERIA; CALCIUM PHOSPHATES; DELAYED-ACTION PREPARATIONS; DENTAL CEMENTS; DOXYCYCLINE; KINETICS; MATERIALS TESTING; PERIODONTAL DISEASES;

EID: 43049091602     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31610     Document Type: Article

References (28)

1. Albandar JM. Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 2005;49:517-532.
2. Bokor-Bratic M, Brkanic T. Clinical use of tetracyclines in the treatment of periodontal diseases. Med Pregl 2000;53:266-271.
3. Parfitt K. Martindale: The Complete Drug Reference. London: Pharmaceutical Press; 1999. p 203, 260.
4. Ramamurthy NS, Rifkin BR, Greenwald RA, Xu JW, Liu Y, Turner G, Golub LM, Vernillo AT. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: A comparison of 6 chemically modified tetracyclines. J Periodontol 2002;73:726-734.
5. Hanes PJ, Purvis JP. Local anti-infective therapy: Pharmacological agents. A systematic review. Ann Periodontol 2003;8:79-98.
6. Tomasi C, Wennstrom JL. Locally delivered doxycycline improves the healing following non-surgical periodontal therapy in smokers. J Clin Periodontol 2004;31:589-595.
7. Johnson LR, Stoller NH. Rationale for the use of Atridox therapy for managing periodontal patients. Compend Contin Educ Dent 1999;20:19-25.
8. Ciancio SG. Site specific delivery of antimicrobial agents for periodontal disease. Gen Dent 1999;47:172-178.
9. Walker C. The supplemental use of antibiotics in periodontal therapy. Compend Contin Educ Dent 1999;20:4-12.
10. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 1998;69:1085-1091.
11. Bohner M, Gbureck U, Barralet JE. Technological issues for the development of more efficient calcium phosphate bone cements: A critical assessment. Biomaterials 2005;26:6423-6429.
12. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: A review. J Control Release 2006;113:102-110.
13. Ratier A, Gibson IR, Best SM, Freche M, Lacout JL, Rodriguez F. Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline. Biomaterials 2001;22:897-901.
14. Barralet JE, Grover LM, Gbureck U. Ionic modification of calcium phosphate cement viscosity. II. Hypodermic injection and strength improvement of brushite cement. Biomaterials 2004;25:2197-2203.
15. Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol 1986;1:48-57.
16. Slots J, Reynolds HS. Long-wave UV light fluorescence for identification of black-pigmented Bacteroides spp. J Clin Microbiol 1982;16:1148-1151.
17. Jacinto RC, Gomes BP, Ferraz CC, Zaia AA, Filho FJ. Microbiological analysis of infected root canals from symptomatic and asymptomatic teeth with periapical periodontitis and the antimicrobial susceptibility of some isolated anaerobic bacteria. Oral Microbiol Immunol 2003;18:285-292.
18. Bohner M, Lemaitre J, VanLanduyt P, Zambelli PY, Merkle HP, Gander B. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci 1997;86:565-572.
19. Kaitila I. The mechanism by which tetracycline hydrochloride inhibits mineralization in vitro. Biochim Biophys Acta Gen Subj 1971;244:584-594.
20. Song Z, Zhou D, Yin G, Zheng C. In vitro release of tetracycline hydrochloride from α-TCP cement. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2003;20:586-589.
21. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961;50:874-875.
22. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-133.
23. Peppas NA, Analysis of Fickian and non Fickian drug release velocity upon surface from polymers. Pharm Act Helv 1985;60:110-111.
24. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements: Competitive drug carriers for the musculoskeletal system? Biomaterials 2006;27:2171-2177.
25. Caswell AH, Hutchison JD. Selectivity of cation chelation to tetracyclines: Evidence for special conformation of calcium chelate. Biochem Biophys Res Coram 1971;43:625-630.
26. 2+. Photochem Photobiol Sci 2003;2:1107-1117.
27. Davies AK, Cundall RB, Dandiker Y, Slifkin MA. Photo-oxidation of tetracycline odsorbed on hydroxyapatite in relation to the light induced staining of teeth. J Dent Res 1985;64:936-939.
28. Choi DH, Moon IS, Choi BK, Paik JW, Kim YS, Choi SH, Kim CK. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res 2004;39:20-26.